Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure: meta-analysis.

Xie F, Yan L, Lu J, Zheng T, Shi C, Ying J, Shen R, Yang J.

PLoS One. 2013;8(1):e54773. doi: 10.1371/journal.pone.0054773. Epub 2013 Jan 28.

PMID:
23382964
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F.

N Engl J Med. 2008 Dec 4;359(23):2442-55. doi: 10.1056/NEJMoa0802878.

PMID:
19052126
[PubMed - indexed for MEDLINE]
Free Article
3.

Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

Keating GM.

Drugs. 2011 Dec 24;71(18):2511-29. doi: 10.2165/11208510-000000000-00000. Review.

PMID:
22141390
[PubMed - indexed for MEDLINE]
4.

Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.

Lok AS, Trinh H, Carosi G, Akarca US, Gadano A, Habersetzer F, Sievert W, Wong D, Lovegren M, Cohen D, Llamoso C.

Gastroenterology. 2012 Sep;143(3):619-28.e1. doi: 10.1053/j.gastro.2012.05.037. Epub 2012 May 27.

PMID:
22643350
[PubMed - indexed for MEDLINE]
5.

Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.

Dienstag JL, Wei LJ, Xu D, Kreter B.

Clin Drug Investig. 2007;27(1):35-49. Review.

PMID:
17177578
[PubMed - indexed for MEDLINE]
6.

Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.

Cui YL, Yan F, Wang YB, Song XQ, Liu L, Lei XZ, Zheng MH, Tang H, Feng P.

Dig Dis Sci. 2010 Aug;55(8):2373-80. doi: 10.1007/s10620-010-1257-7. Epub 2010 May 29.

PMID:
20512414
[PubMed - indexed for MEDLINE]
7.

Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.

Chen T, He Y, Liu X, Yan Z, Wang K, Liu H, Zhang S, Zhao Y.

Clin Exp Med. 2012 Sep;12(3):159-64. doi: 10.1007/s10238-011-0160-7. Epub 2011 Oct 15.

PMID:
22002708
[PubMed - indexed for MEDLINE]
8.

Treatment of chronic hepatitis B: Evolution over two decades.

Yuen MF, Lai CL.

J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:138-43. doi: 10.1111/j.1440-1746.2010.06545.x. Review.

PMID:
21199525
[PubMed - indexed for MEDLINE]
9.

The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis.

Yu S, Jianqin H, Wei W, Jianrong H, Yida Y, Jifang S, Liang Y, Zhi C, Hongyu J.

Ann Hepatol. 2013 May-Jun;12(3):364-72. Review.

PMID:
23619252
[PubMed - indexed for MEDLINE]
10.

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, Lok AS, Han KH, Goodman Z, Zhu J, Cross A, DeHertogh D, Wilber R, Colonno R, Apelian D; BEHoLD AI463022 Study Group.

N Engl J Med. 2006 Mar 9;354(10):1001-10.

PMID:
16525137
[PubMed - indexed for MEDLINE]
Free Article
11.

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Gurel S, Snow-Lampart A, Borroto-Esoda K, Mondou E, Anderson J, Sorbel J, Rousseau F.

Gastroenterology. 2011 Jan;140(1):132-43. doi: 10.1053/j.gastro.2010.10.011. Epub 2010 Oct 16.

PMID:
20955704
[PubMed - indexed for MEDLINE]
12.

Entecavir: a review of its use in chronic hepatitis B.

Scott LJ, Keating GM.

Drugs. 2009 May 29;69(8):1003-33. doi: 10.2165/00003495-200969080-00005. Review.

PMID:
19496629
[PubMed - indexed for MEDLINE]
13.

A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B.

Ren FY, Piao DM, Piao XX.

World J Gastroenterol. 2007 Aug 21;13(31):4264-7.

PMID:
17696259
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B.

Dakin H, Fidler C, Harper C.

Value Health. 2010 Dec;13(8):934-45. doi: 10.1111/j.1524-4733.2010.00777.x. Epub 2010 Sep 3.

PMID:
20825624
[PubMed - indexed for MEDLINE]
15.

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F; Club Epatologi Ospedalieri (CLEO) Group.

Clin Ther. 2008 Feb;30(2):317-23. doi: 10.1016/j.clinthera.2008.02.012.

PMID:
18343270
[PubMed - indexed for MEDLINE]
16.

Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.

Pan CQ, Hu KQ, Yu AS, Chen W, Bunchorntavakul C, Reddy KR.

J Viral Hepat. 2012 Mar;19(3):213-9. doi: 10.1111/j.1365-2893.2011.01533.x. Epub 2011 Oct 17.

PMID:
22329376
[PubMed - indexed for MEDLINE]
17.

Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

Rivkin A.

Drugs Today (Barc). 2007 Apr;43(4):201-20. Review.

PMID:
17460784
[PubMed - indexed for MEDLINE]
18.

[Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load].

Chen LB, Cao H, Zhang YF, Shu X, Chen N, Zhang K, Li G, Xu QH.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Oct;24(5):364-6. Chinese.

PMID:
21280326
[PubMed - indexed for MEDLINE]
19.

High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B.

Chae HB, Kim MJ, Seo EG, Choi YH, Lee HS, Han JH, Yoon SM, Park SM, Youn SJ.

Korean J Hepatol. 2012 Mar;18(1):75-83. doi: 10.3350/kjhep.2012.18.1.75. Epub 2012 Mar 22.

PMID:
22511906
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.

Gish RG, Chang TT, Lai CL, de Man R, Gadano A, Poordad F, Yang J, Brett-Smith H, Tamez R.

J Viral Hepat. 2010 Jan;17(1):16-22. doi: 10.1111/j.1365-2893.2009.01146.x. Epub 2009 Jul 19.

PMID:
19622117
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk